RecruitingNot ApplicableNCT03775837
Effect of Panax Ginseng C.A. Mey Extract on Liver Function in Adults
Effect of Panax Ginseng C.A. Mey Extract on Liver Function in Adults: a Randomized, Double-blinded, Placebo-controlled Trial
Sponsor
Pusan National University Yangsan Hospital
Enrollment
60 participants
Start Date
Dec 1, 2018
Study Type
INTERVENTIONAL
Conditions
Summary
The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Panax Ginseng C.A. Mey Extract on liver function in adults for 8 weeks.
Eligibility
Min Age: 19 YearsMax Age: 75 Years
Inclusion Criteria1
- ALT ranging from upper limit of reference to three times of upper limit
Exclusion Criteria8
- Abnormal liver or renal function (i.e., serum aminotransferase activity > 3 times of upper limit of reference range and serum creatinine concentrations > 1.2 mg/dL)
- Diabetes (diagnosed clinically or fasting glucose level > 126 mg/dL)
- History of viral hepatitis or cancer
- Uncontrolled hypertension
- History of serious cardiac disease such as angina or myocardial infarction
- History of gastrectomy
- History of medication for psychiatric disease
- Administration of oriental medicine including herbs within the past 4 weeks
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIETARY_SUPPLEMENTPanax Ginseng C.A. Mey Extract group
This group takes Panax Ginseng C.A. Mey Extract for 8 weeks
DIETARY_SUPPLEMENTPlacebo group
This group takes placebo for 8 weeks
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03775837
Related Trials
Comparison of Inflammatory Profiles and Regenerative Potential in Alcoholic Liver Disease
NCT037738871 location
China Metastatic Liver Cancer Clinical Registry Cohort Database
NCT076025043 locations
The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine
NCT071506241 location
Impact of Iron Overload on the Incidence of Liver Complications in Long-Term Survivors (≥10 Years) of Allogeneic Hematopoietic Stem-Cell Transplantation.
NCT070281121 location
Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting Time
NCT0687429610 locations